INTERVIEW: Is Edico’s DRAGEN the new Ferrari of genome bioinformatics?
This article was originally published in Clinica
Executive Summary
The trend for big technology companies getting increasingly involved in the medical device arena isn’t going away anytime soon, and it could have a big impact on the sector. “I think it’s going to change the industry significantly in years to come,” Pieter Van Rooyen, CEO of bioinformatics specialist Edico Genome told Clinica.